SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Altor BioScience Corporation Awarded $3 MM SBIR Bridge Grant by National Cancer Institute to Advance Clinical Trials for its Targeted Cancer Therapeutic ALT-801